Provectus Biopharma (PVCT) Reports Q1 Loss of $0.04/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. DOX
5. VRTX
6. CRWD
7. CHKP
8. ON
9. HNGE
10. INSP

Go back to Provectus Biopharma (PVCT) Reports Q1 Loss of $0.04/Share

Provectus Biopharmaceuticals, Inc. Reports First Quarter 2016 Financial Results

May 10, 2016 6:12 PM EDT

KNOXVILLE, Tenn.--(BUSINESS WIRE)-- Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company (Provectus or the "Company), today announced its financial results for the first quarter 2016 ended March 31, 2016.

First Quarter Results and Balance Sheet Highlights

Our cash and cash equivalents were $9,760,997 at March 31, 2016, compared with $14,178,902 at December 31, 2015. The... More